INDmoney
Medicamen Biotech Ltd Q3 FY2025-2026 Results: Summary
Revenue | ₹47.44Cr |
Net Profits | ₹2.19Cr |
Net Profit Margins | 4.62% |
Medicamen Biotech Ltd’s revenue jumped 4.77% since last year same period to ₹47.44Cr in the Q3 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated -0.21% fall in its revenue since last 3-months.
Medicamen Biotech Ltd’s net profit fell -36.89% since last year same period to ₹2.19Cr in the Q3 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated -17.98% fall in its net profits since last 3-months.
Medicamen Biotech Ltd’s net profit margin fell -39.76% since last year same period to 4.62% in the Q3 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated -17.8% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Medicamen Biotech Ltd in Q3 results 2025?
The revenue for Medicamen Biotech Ltd in the Q3 results 2025 was ₹47.44Cr.
What was the net profit for Medicamen Biotech Ltd in Q3 results 2025?
The net profit for Medicamen Biotech Ltd in the Q3 results 2025 was ₹2.19Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q3 results 2025?
The net profit margin for Medicamen Biotech Ltd in the Q3 results 2025 was 4.62%.
What was the revenue for Medicamen Biotech Ltd in Q3 results 2024?
The revenue for Medicamen Biotech Ltd in the Q3 results 2024 was ₹45.28Cr.
What was the net profit for Medicamen Biotech Ltd in Q3 results 2024?
The net profit for Medicamen Biotech Ltd in the Q3 results 2024 was ₹3.47Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q3 results 2024?
The net profit margin for Medicamen Biotech Ltd in the Q3 results 2024 was 7.66%.
